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A 68-year-old man with dilated cardiomyopathy (left ventricular ejection fraction, 15%) and non-
sustained ventricular tachycardia received an implantable cardioverter deﬁbrillator. Even though his
cardiac status had greatly improved 2 years later after b-blocker therapy, he experienced 2 episodes of
sudden shock when he was squatting in a bathroom without any preceding symptoms. His serum
electrolyte and plasma glucose levels were normal. Interrogation of the device revealed that the shock
was caused by sinus tachycardia and T-wave oversensing. A number of episodes of nonsustained
ventricular tachycardia due to T-wave oversensing was also recorded. Follow-up interrogation of the
device with the patient in the supine position could not reproduce the T-wave oversensing. We were
able to elicit T-wave oversensing only after reproduction of the patient’s clinical situation using
isoproterenol and postural changes (i.e., sinus tachycardia and squatting). This case suggests that
sudden increases in nonsustained ventricular tachycardia events may be caused by T-wave over-
sensing, and postural changes should be taken into consideration in such situations.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
T-wave oversensing in implantable cardioverter deﬁbrillators
remains a problem that requires a solution [1–5]. Although this
phenomenon may be a manufacturer-related technical problem,
several situations have been reported to cause or contribute to the
onset of T-wave oversensing [6–16]. We report here a case of
inappropriate shock administration that was caused by T-wave
oversensing and that was induced by the patient’s postural changes.2. Case report
A 68-year-old man with dilated cardiomyopathy [Left ventri-
cular (LV) ejection fraction, 15%] of unknown etiology and non-
sustained ventricular tachycardia was referred to our institution.
He was prescribed a b-blocker (2.5 mg of carvedilol, which was
gradually increased to 20 mg) and 200 mg of amiodarone. Due
to frequent nonsustained ventricular tachycardia, he received
an implantable cardioverter deﬁbrillator (ICD) (GEM2 DR Model
7273, Medtronic Inc., Minneapolis, MN, USA) with an active
ﬁxation, dedicated bipolar right ventricular deﬁbrillation/sensing
lead (SPRINT Model 6943, Medtronic Inc.) for the primaryrt Rhythm Society. Published by E
:þ81 82 255 7360.prevention of sudden cardiac death. The tip of the deﬁbrillation
lead was screwed into the upper part of the interventricular
septum of the right ventricle. The detection and therapy protocol
were set for 3 zones (Table 1). Even though the patient’s LV function
had greatly improved 2 years later (LV ejection fraction, 60%),
several episodes of nonsustained ventricular tachycardia were
detected at the device follow-up. However, the patient denied the
presence of any symptoms, and these events were so brief that no
electrograms were recorded in the ICD. In addition, his serum
electrolyte and plasma glucose levels were normal, and the QT
interval of his surface electrocardiogram was normal.
The patient was then placed under observation. One month
later, he complained of 2 episodes of sudden shock when he was
squatting in the bathroom. Palpitations or preceding symptoms
were absent. Interrogation of the ICD revealed many episodes of
nonsustained ventricular tachycardia, as well as 2 episodes of
inappropriate shock therapy, all of which were due to T-wave
oversensing (Fig. 1A–B). Three episodes of ventricular ﬁbrillation
(VF), 1 episode of fast ventricular tachycardia (FVT), and 118
episodes of nonsustained ventricular tachycardia were recorded
during the 3-month period. Fig. 1A shows an example of inap-
propriate shock therapy for pseudo VF that occurred at a sinus
rate of 96 beats/min. Although the R–T intervals were about
250 ms and the T–R intervals about 360 ms in this episode, shock
therapy was administered according to the combined counting
criterion for the Medtronic ICD [17]. Fig. 1B shows an example of
nonsustained ventricular tachycardia that occurred at a sinus ratelsevier B.V. All rights reserved.
Table 1
The Setting of the ICD parameters.
Detection Rate (bpm) NID initial Rx 1 Rx 2 Rx 3 Rx 4 Rx 5 Rx 6
VF 220–250 18/24 30 J 30 J 30 J 30 J 30 J 30 J
FVT via VF 222–240 18/24 Burst (1) Burst (1) 30 J 30 J 30 J 30 J
VT 150–222 24 Burst (3) Burst (1) Burst (3) Ramp (3) Ramp (3) 30 J
SVT Criteria On: AF/AFL, Sinus Tach, 1:1 SVTs.
Fig. 1. (A) An example of inappropriate shock therapy caused by T-wave oversensing. Although the R–T intervals were about 360 ms and the T–R intervals were about
250 ms, the implantable cardioverter deﬁbrillator (ICD) incorrectly detected ventricular ﬁbrillation with the combined count criterion, and shock therapy was the ﬁrst
therapy administered according to therapy protocol. Note that the inappropriate shock was delivered on a T-wave. (B) An example of pseudo nonsustained ventricular
tachycardia at a sinus rate of 106 beats/min. Note that both the R–T and T–R intervals were about 250–270 ms. This episode continued longer than 2.5 min. In the tracing,
TP was incorrectly inscribed instead of VP. This kind of error sometimes occurs just after anti-tachycardia therapy in GEM2 ICD models. Abbreviations used are as follows:
AR, atrial sensing during refractory period; VS, ventricular sensing; VR, ventricular refractory after charge; CE, charge energy; CD, cardioversion; TP, anti-tachycardia
pacing; VP, ventricular pacing.
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mately 250 ms. Premature ventricular contractions interrupted
consecutive counting repeatedly during sinus tachycardia and
lasted 42.5 min so that inappropriate therapies were not admi-
nistered. Interrogation of the ICD in the supine position did
not reveal T-wave oversensing (Fig. 2). The intrinsic ventricular
amplitude had been 8–9 mV at the time of implantation and was
5 mV after the event, although the surface electrocardiogram
(ECG) showed no change. We decreased the sensitivity from
0.3 mV to 0.5 mV, increased the detection rate of the ventricular
tachycardia zone from 150 to 162 beats/min, increased the
number of intervals to detect (NID) of VF and FVT from 18/24 to
24/32, and increased the dose of carvedilol to 30 mg in order to
slow the sinus rate. However, multiple episodes of nonsustained
ventricular tachycardia that were caused by T-wave oversensing
were still recorded during a 1-week period, and the patient
complained of dizziness because of orthostatic hypotension.
We next reviewed the shock episodes and intracardiac
electrograms and found that the episodes occurred only when
the patient had sinus tachycardia and was squatting. Therefore,
we tried to reproduce the situation by infusing isoproterenol
and having the patient squat and were successful in ﬁnally
demonstrating T-wave oversensing (Fig. 3). Fortunately, the
patient’s heart function had signiﬁcantly improved as a result of
b-blocker therapy so that the primary prevention of sudden
cardiac death was no longer necessary. After a deﬁbrillation
threshold test was successfully performed at the sensingthreshold of 1.2 mV, the detection of the threshold of ventricular
ﬁbrillation was set at 250 min1 with the sensing threshold set at
0.3 mV, and the detection of ventricular tachycardia was turned
off. No further episodes of T-wave oversensing or any other
clinical events have been recorded for the past 4.5 years.3. Discussion
We herein report a case of inappropriate shock therapy that
was caused by T-wave oversensing and that occurred when the
patient had sinus tachycardia and was squatting. Several methods
were considered to troubleshoot this problem. We decreased the
sensitivity and increased the NID and detection rate of ventricular
tachycardia in order to satisfy the combined count criterion;
however, a number of nonsustained ventricular tachycardia events
caused by T-wave oversensing were still recorded. Further short-
ening of the detection intervals of the ventricular tachycardia
zone would not be sufﬁcient because a number of nonsustained
ventricular tachycardias with short R–T and T–R intervals (about
250 ms) were also recorded. Therefore, changes in these para-
meters could not sufﬁciently resolve the problem. In addition,
these methods can also cause delayed detection of true fatal
ventricular events. Medication to slow the heart rate was admi-
nistered for a week, but the patient could not tolerate it.
Repositioning of the lead was a possible solution, but endothe-
lialization of the lead body may have prevented manipulation
Fig. 2. Electrograms (EGMs) recorded in the supine position. The T-waves were so small that there was no T-wave oversensing. Abbreviations used are as follows: AP, atrial
pacing; VS, ventricular sensing.
Fig. 3. Reproduction of T-wave oversensing induced by isoproterenol infusion and a postural change. The amplitudes of the R-waves temporarily increased and were
signiﬁcantly reduced after squatting. This resulted in T-wave oversensing despite the fact that the amplitudes of the T-waves remained the same. Abbreviations used are as
follows: AS, atrial sensing; TS, ventricular sensing of VT zone; TF, ventricular sensing of VF zone; FS, ventricular sensing of FVT zone.
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case. An additional lead for ventricular sensing or replacement of
the ICD with one from another manufacturer or from the new
generation of Medtronic ICDs was a desirable solution in such
situations [3–8,12–16,18,19]. However, all of these methods are
expensive and require additional operations, which may cause
complications [20]. The patient’s cardiac status had improved so
signiﬁcantly that aggressive intervention for ventricular tachy-
cardia to prevent sudden cardiac death was no longer necessary,
although the possibility of sudden cardiac death could not be
excluded. We decided to stop the therapy except in the ventri-
cular ﬁbrillation zone. Consequently, his clinical course has
been good.
Themost important aspect in this case was how tomake a correct
diagnosis. The sudden appearance of nonsustained ventricular
tachycardia 1 month before inappropriate shock therapy may have
been caused by T-wave oversensing. Although the diagnosis of
inappropriate shock therapy was ﬁnally made by intracardiac
electrograms, interrogation of the device in the supine position did
not demonstrate T-wave oversensing. We then reproduced the
clinical situation by isoproterenol infusion and a postural change
(i.e., sinus tachycardia and squatting position) to ﬁnally demonstrate
T-wave oversensing. There were 3 important factors involved in the
observed phenomenon: sinus tachycardia, squatting, and a decrease
in R-wave amplitude. In addition to T-wave oversensing, sinus
tachycardia was required to satisfy the detection rate. A decrease
in R-wave amplitude has been reported to be an important factor for
T-wave oversensing [2,12–15]. Although the present patient’s cardiac
function had signiﬁcantly improved and his surface ECG showed no
changes, the intrinsic R-wave amplitude had decreased from 8–9mV
to 5mV. Interestingly, sinus tachycardia increased the T-wave
amplitude. Adrenergic stimulation causes sinus tachycardia and
may have affected depolarization and local electrograms. In addition,
squatting reduced the R-wave amplitude further, resulting in T-waveoversensing. Regarding the lead system, a true bipolar lead report-
edly lowers the risk of T-wave oversensing [20]. Although the lead
used was true bipolar, an active ﬁxation lead was screwed into the
upper part of the interventricular septum of the right ventricle in
this patient. The distal tip of an active ﬁxation lead may be less
endothelialized and more ﬂexible than that of a passive ﬁxation lead
because the lead can be ﬁxed only by screwing. In addition, postural
change may affect the angle between the distal tip of the lead and
the local myocardium and cause electrogram variation. Although the
true mechanism responsible for these variations in electrograms is
unknown, this phenomenon should be taken into consideration
when T-wave oversensing is suspected or when intermittent reduc-
tions of R-wave amplitudes are observed [13,14]. In addition, multi-
ple episodes of nonsustained tachycardia were recorded before the
episodes of inappropriate shock therapy. Therefore, when multiple
nonsustained ventricular tachycardia events without suspicious
causes are newly detected or the frequency suddenly increases, the
possibility of T-wave oversensing should be considered.Conﬂict of interest
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